1,067 reports of this reaction
1.4% of all FILGRASTIM reports
#18 most reported adverse reaction
BONE PAIN is the #18 most commonly reported adverse reaction for FILGRASTIM, manufactured by Amgen, Inc. There are 1,067 FDA adverse event reports linking FILGRASTIM to BONE PAIN. This represents approximately 1.4% of all 76,865 adverse event reports for this drug.
Patients taking FILGRASTIM who experience bone pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BONE PAIN is a less commonly reported adverse event for FILGRASTIM, but still significant enough to appear in the safety profile.
In addition to bone pain, the following adverse reactions have been reported for FILGRASTIM:
The following drugs have also been linked to bone pain in FDA adverse event reports:
BONE PAIN has been reported as an adverse event in 1,067 FDA reports for FILGRASTIM. This does not prove causation, but indicates an association observed in post-market surveillance data.
BONE PAIN accounts for approximately 1.4% of all adverse event reports for FILGRASTIM, making it a notable side effect.
If you experience bone pain while taking FILGRASTIM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.